Third quarter 2025 GAAP net income of $4.05 million or $0.30 per basic weighted average common share and Distributable ...
Conference call scheduled for November 13, 2025 at 8:00am ET Commercial launch of ZELSUVMI, the first FDA-approved at-home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback